Physician profile
David Gonzalez
NPI 1043208218
$6,048.66
in general payments reported to CMS, 2019-2025
17 companies · $2,465 in 2025
The $2,465 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $269 · 2021: $435 · 2022: $870 · 2023: $581 · 2024: $754 · 2025: $2,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,845 · Travel and Lodging: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,844.77 |
| Travel and Lodging | $954.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,945.78 | 2021-2025 | Symplicity G3, Micra |
| Boston Scientific Corporation | $1,923.60 | 2019-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Shockwave Medical, INC | $932.71 | 2021-2025 | |
| Abbott Laboratories | $389.55 | 2019-2025 | Merlin@Home, Assurity, Gallant |
| Medtronic Vascular, INC. | $229.28 | 2019-2020 | |
| Pfizer INC. | $216.51 | 2019-2025 | |
| Ge Healthcare | $106.95 | 2024 | |
| Biotronik INC. | $62.60 | 2024 | Biomonitor |
| Janssen Pharmaceuticals, INC | $58.40 | 2021-2022 | |
| Amgen INC. | $37.73 | 2022-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $27.58 | 2020-2022 | |
| Edwards Lifesciences Corporation | $25.64 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.36 | 2021-2022 | |
| Abiomed | $18.52 | 2021 | |
| Penumbra, INC. | $16.94 | 2024 | Indigo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.94 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.